Abstract
Background
Studies on low-level As exposure have not found an association with cancer, while increased risks were reported for skin lesions, respiratory and cardiovascular diseases and reproductive outcomes. Prospective observational studies with individual exposure measures are needed to study low-level As exposure effects. In a geothermal area in Southern Tuscany (Italy), characterized by a natural presence of As in drinking water (< 50 µg/l), As urinary concentrations were measured in a survey in 1998 and cohort members were followed to evaluate the effects on health.
Methods
Around 900 subjects (20–55 years old) randomly sampled in 4 municipalities of the area (Monte Amiata), have been followed from 1999 to 2015, by hospitalisation and mortality registries. Standardized Hospitalisation Ratios (SHRs) were performed, compared to a reference area. Competing-risks regression models were performed to test the association between As urinary concentration and risk of first hospitalisation.
Results
SHRs show various increased risks, more frequently among males. Internal analyses show a positive association between As and skin diseases in the general population, the Hazard Ratio (HR) for 1 µg/l increase of As urinary concentration is 1.06 (90%CI 1.01–1.11) and in males, HR 1.08 (90%CI 1.02–1.14), between As and circulatory system diseases in males, HR 1.03 (90%CI 1.01–1.05).
Conclusions
The results suggest an effect on skin diseases and circulatory system diseases and, considering the relative young age of cohort members, they could be considered also as predictive of future severer diseases.
Similar content being viewed by others
References
Agency for Toxic Substances and Disease Registry (ATSDR) (2007) Toxicological profile for Arsenic. US Department of Health and Human Services, Public Health Service, Atlanta
Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I et al (2006) Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol 163:1138–1148
Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T et al (2011) A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol 174(2):185–194
Baastrup R, Sørensen M, Balstrøm T, Frederiksen K, Larsen CL, Tjønneland A et al (2008) Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect 116(2):231–237. https://doi.org/10.1289/ehp.10623
Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D et al (2004) Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 159(4):381–389
Bavazzano P, Perico A, Rosendahl H, Apostoli P (1996) Determination of urinary arsenic by solvent extraction and electrothermal atomic absorption spectrometry. A comparison with directly coupled high performance liquid chromatography-indiclively coupled plasma mass spectrometry. J Anal At Spectrom 11:521–524. https://doi.org/10.1039/JA9961100521
Begum M, Horowitz J, Hossain MI (2015) Low-dose risk assessment for arsenic: a meta-analysis approach. Asia Pac J Public Health 27(2):NP20–N35. https://doi.org/10.1177/1010539512466568
Bustaffa E, Minichilli F, Andreassi MG, Carone S, Coi A, Cori L et al (2014) Studies on markers of exposure and early effect in areas with arsenic pollution: methods and results of the project SEpiAs. Epidemiological surveillance in areas with environmental pollution by natural or anthropogenic arsenic. Epidemiol Prev 38(3–4 Suppl 1):27–94
Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, Tao X et al (2008) Arsenic in drinking water and lung cancer: a systematic review. Environ Res 108(1):48–55. https://doi.org/10.1016/j.envres.2008.04.001
Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M et al (2009) Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239(2):184–192. https://doi.org/10.1016/j.taap.2009.01.010 (Epub 2009 Jan 27)
Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Wang YH et al (2010) Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan. Cancer Epidemiol Biomarkers Prev 19(1):101–110. https://doi.org/10.1158/1055-9965.EPI-09-0333
Engel RR, Smith AH (1994) Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 countries in the United States. Arch Environ Health 49(5):418–427
Ferreccio C, Gonzales C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673–679
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509. https://doi.org/10.1080/01621459.1999.10474144
Guha Mazumder DN, Haque R, Ghosh N, De BH, Santra A, Chakraborty D et al (1998) Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 27(5):871–877
Han YY, Weissfeld JL, Davis DL, Talbott EO (2009) Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study. Int Arch Occup Environ Health 82(7):843–849
Hartwig A, MAK Commission (2016) Arsenic and its inorganic compounds (with the Exception of Arsine), vol. 1. The Mak-Collection for Occupational Health and Safety: annual thresholds and classifications for the workplace. https://doi.org/10.1002/3527600418.mb744038vere5716
Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H et al (1996) Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7(2):117–124
Hopenhayn-Rich C, Biggs ML, Smith AH (1998) Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol 27(4):561–569
IARC (2012) Arsenic and arsenic compounds. IARC Monogr Eval Carcinog Risks Hum 100C:41–93
Islam MR, Khan I, Attia J, Hassan SM, McEvoy M, D’Este C et al (2012) Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in Bangladesh. Int J Environ Res Public Health 9(12):4522–4536
Kurttio P, Pukkala E, Kahelin A, Auvinen A, Pekkanen J (1999) Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705–710
Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K et al (2012) Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect 120(5):721–726. https://doi.org/10.1289/ehp.1103534 (Epub 2012 Jan 31)
Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL (1999) Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107(5):359–365
Lisabeth LD, Ahn HJ, Chen JJ, Sealy-Jefferson S, Burke JF, Meliker JR (2010) Arsenic in drinking water and stroke hospitalisations in Michigan. Stroke 41(11):2499–2504
Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J et al (2012) Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120(12):1658–1670. https://doi.org/10.1289/ehp.1104579 (Epub 2012 Aug 10)
McDonald C, Hoque R, Huda N, Cherry N (2007) Risk of arsenic-related skin lesions in Bangladeshi villages at relatively low exposure: a report from Gonoshasthaya Kendra. Bull World Health Organ 85(9):668–673
Medrano MAJ, Boix R, Pastor-Barriuso R, Palau M, Damián J, Ramis R et al (2010) Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res 110:448–454
Minichilli F, Nuvolone D, Bustaffa E, Cipriani F, Vigotti MA, Bianchi F (2012) State of health of populations residing in geothermal areas of Tuscany. Epidemiol Prev 36(5 Suppl 1):1–104
Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS (2008) Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310. https://doi.org/10.1016/j.yrtph.2008.08.010 (Epub 2008 Aug 26)
Moon K, Guallar E, Navas-Acien A (2012) Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep 14(6):542–555. https://doi.org/10.1007/s11883-012-0280-x
Myers SL, Lobdell DT, Liu Z, Xia Y, Ren H, Li Y et al (2010) Maternal drinking water arsenic exposure and perinatal outcomes in inner Mongolia, China. J Epidemiol Community Health 64(4):325–329. https://doi.org/10.1136/jech.2008.084392 (Epub 2009 Aug 19)
Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E (2006) Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect 114(5):641–648
Parvez F, Chen Y, Brandt-Rauf PW, Slavkovich V, Islam T, Ahmed A et al (2010) A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the Health Effects of Arsenic Longitudinal Study (HEALS). Thorax 65(6):528–533. https://doi.org/10.1136/thx.2009.119347
Rahman M, Vahter M, Sohel N, Yunus M, Wahed MA, Streatfield PK et al (2006) Arsenic exposure and age and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ Health Perspect 114(12):1847–1852
Sanchez TR, Perzanowski M, Graziano JH (2016) Inorganic arsenic and respiratory health, from early life exposure to sex-specific effects: a systematic review. Environ Res 147:537–555. https://doi.org/10.1016/j.envres.2016.02.009
Stea F, Faita F, Borghini A, Faita F, Bianchi F, Bustaffa E et al (2016) Arsenic and subclinical vascular damage in a sample of Italian young adults: a cross-sectional analysis. Environ Sci Pollut Res Int 23(20):20307–20314 (Epub 2016 Jul 23)
Wadhwa SK, Kazi TG, Chandio AA, Afridi HI, Kolachi NF, Khan S et al (2011) Comparative study of liver cancer patients in arsenic exposed and non-exposed areas of Pakistan. Biol Trace Elem Res 144(1–3):86–96. https://doi.org/10.1007/s12011-011-9036-7
WHO (1996) Biological monitoring of chemical exposure in the workplace, vol 1. World Health Organization, Geneva
Xia Y, Wade TJ, Wu K, Li Y, Ning Z, Le XC et al (2009) Well water arsenic exposure, arsenic induced skin-lesions and self-reported morbidity in Inner Mongolia. Int J Environ Res Public Health 6(3):1010–1025
Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M et al (2010) Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 21(1):103–108. https://doi.org/10.1097/EDE.0b013e3181c21e46
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Stefano Belli: currently retired.
Rights and permissions
About this article
Cite this article
Profili, F., Nuvolone, D., Barbone, F. et al. Health effects among a cohort exposed to low-level arsenic in a geothermal area of Tuscany, Italy. Int Arch Occup Environ Health 91, 971–979 (2018). https://doi.org/10.1007/s00420-018-1340-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-018-1340-5